Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Jun;88(3):410–413. doi: 10.1111/j.1365-2249.1992.tb06463.x

Anti-endothelial cell antibodies in insulin-dependent diabetes mellitus.

A G Wangel 1, S Kontiainen 1, T Scheinin 1, A Schlenzka 1, D Wangel 1, J Mäenpää 1
PMCID: PMC1554508  PMID: 1606723

Abstract

The prevalence of IgG class antibodies to endothelial cells (AECA) was studied in 136 young patients with insulin-dependent diabetes mellitus by an enzyme immunoassay using human umbilical cord vein endothelial cells. The patients were divided into four groups according to the time between diagnosis and study and their results were compared with those in control children and blood donors. AECA became progressively more frequent with the duration of diabetes, being 4% in diabetics tested within 2 weeks of diagnosis and reaching 34% after an average disease duration of 11.2 years. They were not more common in patients with neuropathy, retinopathy or nephropathy than in patients without these complications, but were associated with co-existing thyroid disease and IgA deficiency. The results suggest that in insulin-dependent diabetes mellitus AECA are associated with co-existing autoimmune disorders but not with diabetic microvascular disease.

Full text

PDF
410

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammann A. J., Hong R. Selective IgA deficiency and autoimmunity. Clin Exp Immunol. 1970 Dec;7(6):833–838. [PMC free article] [PubMed] [Google Scholar]
  2. Ammann A. J., Hong R. Unique antibody to basement membrane in patients with selective IgA deficiency and coeliac disease. Lancet. 1971 Jun 19;1(7712):1264–1266. doi: 10.1016/s0140-6736(71)91779-x. [DOI] [PubMed] [Google Scholar]
  3. BERSON S. A., YALOW R. S., BAUMAN A., ROTHSCHILD M. A., NEWERLY K. Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. J Clin Invest. 1956 Feb;35(2):170–190. doi: 10.1172/JCI103262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bottazzo G. F., Dean B. M., McNally J. M., MacKay E. H., Swift P. G., Gamble D. R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med. 1985 Aug 8;313(6):353–360. doi: 10.1056/NEJM198508083130604. [DOI] [PubMed] [Google Scholar]
  5. Bottazzo G. F., Florin-Christensen A., Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974 Nov 30;2(7892):1279–1283. doi: 10.1016/s0140-6736(74)90140-8. [DOI] [PubMed] [Google Scholar]
  6. Brasile L., Kremer J. M., Clarke J. L., Cerilli J. Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis. Am J Med. 1989 Jul;87(1):74–80. doi: 10.1016/s0002-9343(89)80486-3. [DOI] [PubMed] [Google Scholar]
  7. Cines D. B., Lyss A. P., Reeber M., Bina M., DeHoratius R. J. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest. 1984 Mar;73(3):611–625. doi: 10.1172/JCI111251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fattorossi A., Aurbach G. D., Sakaguchi K., Cama A., Marx S. J., Streeten E. A., Fitzpatrick L. A., Brandi M. L. Anti-endothelial cell antibodies: detection and characterization in sera from patients with autoimmune hypoparathyroidism. Proc Natl Acad Sci U S A. 1988 Jun;85(11):4015–4019. doi: 10.1073/pnas.85.11.4015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ferraro G., Meroni P. L., Tincani A., Sinico A., Barcellini W., Radice A., Gregorini G., Froldi M., Borghi M. O., Balestrieri G. Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immunol. 1990 Jan;79(1):47–53. doi: 10.1111/j.1365-2249.1990.tb05125.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Heurkens A. H., Hiemstra P. S., Lafeber G. J., Daha M. R., Breedveld F. C. Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Immunol. 1989 Oct;78(1):7–12. [PMC free article] [PubMed] [Google Scholar]
  11. Holt C. M., Lindsey N., Moult J., Malia R. G., Greaves M., Hume A., Rowell N. R., Hughes P. Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis. Clin Exp Immunol. 1989 Dec;78(3):359–365. [PMC free article] [PubMed] [Google Scholar]
  12. Jackson R. A., Morris M. A., Haynes B. F., Eisenbarth G. S. Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. N Engl J Med. 1982 Apr 1;306(13):785–788. doi: 10.1056/NEJM198204013061305. [DOI] [PubMed] [Google Scholar]
  13. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kontiainen S., James R. L., Feldman M. Human islet cell induced T cell lines and clones from diabetic children. Autoimmunity. 1991;8(3):193–197. doi: 10.3109/08916939108997106. [DOI] [PubMed] [Google Scholar]
  15. Kontiainen S., Schlenzka A., Koskimies S., Rilva A., Mäenpä J. Autoantibodies and autoimmune diseases in young diabetics. Diabetes Res. 1990 Apr;13(4):151–156. [PubMed] [Google Scholar]
  16. Leung D. Y., Collins T., Lapierre L. A., Geha R. S., Pober J. S. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest. 1986 May;77(5):1428–1435. doi: 10.1172/JCI112454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Leung D. Y., Moake J. L., Havens P. L., Kim M., Pober J. S. Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome. Lancet. 1988 Jul 23;2(8604):183–186. doi: 10.1016/s0140-6736(88)92287-8. [DOI] [PubMed] [Google Scholar]
  18. Rosenbaum J., Pottinger B. E., Woo P., Black C. M., Loizou S., Byron M. A., Pearson J. D. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol. 1988 Jun;72(3):450–456. [PMC free article] [PubMed] [Google Scholar]
  19. Scheinin T., Matikainen E., Groop L., Lepäntalo M., Koskimies S., Kontiainen S. HLA-antigens and immunity to insulin in insulin-dependent diabetics with or without diabetic neuropathy. Scand J Clin Lab Invest. 1988 Jun;48(4):327–332. doi: 10.3109/00365518809167503. [DOI] [PubMed] [Google Scholar]
  20. Scheinin T., Mäenpä J., Kontiainen S. Immune responses to insulin and lymphocyte subclasses at diagnosis of insulin-dependent diabetes and one year later. Immunobiology. 1990 Jun;180(4-5):431–440. doi: 10.1016/s0171-2985(11)80304-9. [DOI] [PubMed] [Google Scholar]
  21. de Berardinis P., Londei M., James R. F., Lake S. P., Wise P. H., Feldmann M. Do CD4-positive cytotoxic T cells damage islet beta cells in type 1 diabetes? Lancet. 1988 Oct 8;2(8615):823–824. doi: 10.1016/s0140-6736(88)92785-7. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES